 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Myovant Sciences Ltd. (MYOV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-02 Purchase | 2019-12-04 6:08 pm | Myovant Sciences Ltd. | MYOV | Roivant Sciences Ltd. 10% Owner | 254,193 | $18.03 | $4,584,356 | 44,763,604 (Direct) | View |
| 2019-11-25 Purchase | 2019-11-27 4:45 pm | Myovant Sciences Ltd. | MYOV | Roivant Sciences Ltd. 10% Owner | 3,500,000 | $15 | $52,500,000 | 44,509,412 (Direct) | View |
| 2019-11-20 Purchase | 2019-11-22 9:28 pm | Myovant Sciences Ltd. | MYOV | Roivant Sciences Ltd. 10% Owner | 243,812 | $12.39 | $3,021,688 | 41,009,412 (Direct) | View |
| 2019-06-12 Purchase | 2019-06-14 4:20 pm | Myovant Sciences Ltd. | MYOV | Sebelius Kathleen Director | 5,000 | $8.957 | $44,784 | 5,000 (Direct) | View |
| 2019-06-04 Purchase | 2019-06-13 3:47 pm | Myovant Sciences Ltd. | MYOV | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-13 3:45 pm | Myovant Sciences Ltd. | MYOV | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-11 Purchase | 2019-06-11 4:55 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 8,000 | $9.1 | $72,800 | 8,000 (Direct) | View |
| 2019-06-04 Purchase | 2019-06-06 8:05 pm | Myovant Sciences Ltd. | MYOV | QVT Associates GP LLC QVT Fund V LP 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:30 pm | Myovant Sciences Ltd. | MYOV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF Holdings (UK) LLP SVF GP (Jersey) Ltd 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:30 pm | Myovant Sciences Ltd. | MYOV | Machado Patrick 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:29 pm | Myovant Sciences Ltd. | MYOV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:07 pm | Myovant Sciences Ltd. | MYOV | Lo Andrew 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:00 pm | Myovant Sciences Ltd. | MYOV | Roivant Sciences Ltd. 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Direct) | View |
| 2019-02-15 Sale | 2019-02-20 4:25 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 260 | $21.15 | $5,499 | 9,740 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-08-26 Option Award | 2019-08-27 4:59 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 37,415 | $0 | 133,500 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:59 pm | N/A 2028-12-16 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 133,500 | $17.28 | 133,500 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:59 pm | N/A 2028-12-16 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 133,500 | $7.78 | 133,500 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:59 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 66,130 | $24.44 | 133,500 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:59 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 66,130 | $7.78 | 133,500 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:58 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 53,615 | $0 | 310,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:58 pm | N/A 2027-07-16 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 310,000 | $11.3 | 310,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:58 pm | N/A 2027-07-16 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 310,000 | $7.78 | 310,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:58 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 87,050 | $21.87 | 310,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:58 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 87,050 | $7.78 | 310,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:58 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 152,110 | $24.44 | 310,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:58 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 152,110 | $7.78 | 310,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:55 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 55,025 | $0 | 200,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:55 pm | N/A 2027-05-14 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 200,000 | $12.68 | 200,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:55 pm | N/A 2027-05-14 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 200,000 | $7.78 | 200,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:55 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 114,690 | $21.87 | 200,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:55 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 114,690 | $7.78 | 200,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:55 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 132,270 | $24.44 | 200,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:55 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 132,270 | $7.78 | 200,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:53 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 47,570 | $0 | 260,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:53 pm | N/A 2027-08-14 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 260,000 | $10.6 | 260,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:53 pm | N/A 2027-08-14 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 260,000 | $7.78 | 260,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:53 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 87,050 | $21.87 | 260,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:53 pm | N/A 2028-04-15 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 87,050 | $7.78 | 260,000 (Direct) | View |
| 2019-08-26 Disposition | 2019-08-27 4:53 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 66,130 | $24.44 | 260,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:53 pm | N/A 2029-04-04 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 66,130 | $7.78 | 260,000 (Direct) | View |
| 2019-08-23 Option Award | 2019-08-27 4:50 pm | N/A 2029-08-22 | Myovant Sciences Ltd. | MYOV | Torti Frank Director | 58,608 | $7.65 | 58,608 (Direct) | View |
| 2019-08-23 Option Award | 2019-08-27 4:48 pm | N/A 2029-08-22 | Myovant Sciences Ltd. | MYOV | Sebelius Kathleen Director | 58,608 | $7.65 | 58,608 (Direct) | View |
| 2019-08-23 Option Award | 2019-08-27 4:46 pm | N/A 2029-08-22 | Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director | 58,608 | $7.65 | 58,608 (Direct) | View |
| 2019-08-23 Option Award | 2019-08-27 4:44 pm | N/A 2029-08-22 | Myovant Sciences Ltd. | MYOV | GUINAN MARK Director | 58,608 | $7.65 | 58,608 (Direct) | View |
| 2019-08-23 Option Award | 2019-08-27 4:42 pm | N/A 2029-08-22 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 58,608 | $7.65 | 58,608 (Direct) | View |
| 2019-04-05 Option Award | 2019-04-09 6:23 pm | N/A 2029-05-04 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 66,130 | $24.44 | 66,130 (Direct) | View |
| 2019-04-05 Option Award | 2019-04-09 6:19 pm | N/A 2029-05-04 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 152,110 | $24.44 | 152,110 (Direct) | View |
| 2019-04-05 Option Award | 2019-04-09 6:16 pm | N/A 2029-05-04 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 66,130 | $24.44 | 66,130 (Direct) | View |
| 2019-04-05 Option Award | 2019-04-09 6:14 pm | N/A 2029-05-04 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 132,270 | $24.44 | 132,270 (Direct) | View |
| 2019-04-05 Option Award | 2019-04-09 6:12 pm | N/A 2029-05-04 | Myovant Sciences Ltd. | MYOV | Seely Lynn Director | 330,660 | $24.44 | 330,660 (Direct) | View |
| 2018-12-17 Option Award | 2018-12-18 5:15 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 29,700 | $0 | 133,500 (Direct) | View |
| 2018-12-17 Option Award | 2018-12-18 5:15 pm | N/A 2028-12-16 | Myovant Sciences Ltd. | MYOV | Sablich Kim Chief Commercial Officer | 133,500 | $17.28 | 133,500 (Direct) | View |
| 2018-11-06 Option Award | 2018-11-08 5:22 pm | N/A 2028-11-05 | Myovant Sciences Ltd. | MYOV | Torti Frank Director | 45,000 | $22.83 | 45,000 (Direct) | View |
| 2018-09-20 Option Award | 2018-09-24 4:42 pm | N/A 2028-09-19 | Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director | 45,000 | $26.17 | 45,000 (Direct) | View |
| 2018-08-31 Option Award | 2018-09-04 4:48 pm | N/A 2028-08-30 | Myovant Sciences Ltd. | MYOV | Sebelius Kathleen Director | 22,500 | $24.25 | 22,500 (Direct) | View |
| 2018-08-31 Option Award | 2018-09-04 4:47 pm | N/A 2028-08-30 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 22,500 | $24.25 | 22,500 (Direct) | View |